10.1097/MCG.0b013e31819f5652 69
PCAC, the Pharmacy Compounding Advisory Committee, is meeting the FDA this week 10 of 12 members on the committee work in businesses aligned with peptides The PCAC recommendation is non-bindingMy take: Let the people inject themselves through regulated channels, via licensed providers and pharmacists There are millions of people injecting themselves with grey market peptides with zero oversight
Age can also play a role, as stomach acid production often decreases in older individuals
Several complex I inhibitors have been evaluated clinically and discontinued due to neurotoxicity and adverse side effects (IACS-010759, Tamoxifen, Piericidin A, Phenformin) (76, 77)
To see the press release which announced this change, go to the Office of Public Sector Information website (opens in a new window)
If you need to travel with reconstituted semaglutide, use an insulated cooler with ice packs